AllianThera Biopharma

Company Drug

AllianThera Biopharma Starts Global Phase I Trial for ATB102 in Inflammatory Bowel Diseases

Fineline Cube Mar 24, 2025

Suzhou-based startup AllianThera Biopharma has announced the first patient dosing in a global Phase I...

Company

Boehringer Ingelheim Reports 6.1% Sales Growth in 2024, Bolstered by Key Pharmaceuticals

Company Deals

GE Healthcare Partners with Probo Medical to Distribute Ultrasound Devices

Company Drug

Henlius Biotech’s HLX04-O Shows Positive Results in wAMD Phase III Trial

Company Drug

Mabwell Bioscience’s 7MW3711 ADC Receives Clinical Trial Approval in China